TECX - Tectonic Therapeutic, Inc. Trailing Twelve Months Revenue Growth

Graphic logo of Tectonic Therapeutic (TECX)

The development of Tectonic Therapeutic, Inc. (TECX) relies on the success of G protein-coupled receptor trials and sufficient post-merger cash reserves to fund R&D. The LTM sales growth YoY metric illustrates the business's maturity stage, where 0.00 characterizes this valuation parameter. Looking ahead, innovative protein platforms for prolonged therapy should provide the company with a stable revenue stream once patents are secured.

TECX Tectonic Therapeutic Revenue Growth YoY (Last 12 Months) (11/23/2025 - 11/18/2026)

Summary analytical data breakdowns for tectonictx.com (TECX)

- current price and projected stock value:
Summary company analytics:TECX tectonictx.com
Manufactured product of Tectonic Therapeutic, Inc.

This indicator is calculated as the percentage change in revenue over the last four quarters relative to the same period last year, measuring business expansion rates and market resilience. For Tectonic Therapeutic, Inc. (TECX), the absence of commercial sales and a focus on R&D make the trailing four-quarter year-over-year sales growth rate a critical marker for the transition from the development stage to monetization.

Who Tectonic Therapeutic, Inc. competes with

Sales Growth YoY (TTM) Haleon Corp HLN|Kenvue Inc - Sales Growth YoY (TTM)|Trailing Twelve Months Revenue Growth veronapharma.com|Jyong Bio (MENS) - Sales Growth YoY (Last Twelve Months)|Revenue Growth Rate YoY (Last Twelve Months) Ligand LGND|AMRX (amneal.com) - Sales Growth YoY (TTM)|PRGO: Revenue Dynamics YoY (Last Twelve Months)|Revenue Growth YoY (Last 12 Months) ALVO (Alvotech Corp)|Annual Revenue Growth (Last Twelve Months) Liquidia Corporation|Sales Growth YoY (TTM) GLPG (glpg.com)|Revenue Dynamics YoY (Last Twelve Months) ANIP|MNKD - Sales Growth YoY (Last Twelve Months)|Amphastar - Revenue Change YoY (Last 12 Months)|PCRX: Sales Growth YoY (TTM)|ars-pharma.com - Revenue Dynamics YoY (Last Twelve Months)|TBPH (Theravance Biopharma Inc) - Sales Growth YoY (TTM)|Trailing Twelve Months Revenue Growth Aquestive Pharma AQST|Sales Growth YoY (TTM) SCPH|TNXP (Tonix Pharmaceuticals Holding) - Revenue Dynamics YoY (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) SXT Pharmaceuticals SXTC|Revenue Dynamics YoY (Last Twelve Months) EPRX|BHST - Sales Growth YoY (Last Twelve Months)|eXoZymes (EXOZ) - Revenue Growth YoY (Last 12 Months)|ORMP: Sales Growth YoY (TTM)|ENTX: Revenue Change YoY (Last 12 Months)|HYFT (ipatherapeutics.com) - Sales Growth YoY (TTM)|Sales Growth YoY (TTM) ABVC BioPharma|Sales Growth YoY (Last Twelve Months) Cumberland Pharmaceuticals Inc. (CPIX)|QNTM (Quantum BioPharma Ltd.) - Revenue Dynamics YoY (Last Twelve Months)|Sales Growth YoY (TTM) FGEN (fibrogen.com)|Telomir Pharmaceuticals (TELO) - Trailing Twelve Months Revenue Growth|RANI - Sales Growth YoY (Last Twelve Months)|Annual Revenue Growth (Last Twelve Months) Synergy CHC SNYR|RLYB: Sales Growth YoY (TTM)|Trailing Twelve Months Revenue Growth Lexaria (LEXX)|Sales Growth YoY (Last Twelve Months) Pulmatrix|Sales Growth YoY (Last 12 Months) PTHL (ftzy.com.cn)|Sales Growth YoY (TTM) APM|Lyra Therapeutics, Inc. - Sales Growth YoY (Last 12 Months)|Sales Growth YoY (TTM) IBO (impactbiomedinc.com)|TNFA: Sales Growth YoY (Last 12 Months)|YCBD - Sales Growth YoY (Last Twelve Months)|PRFX - Sales Growth YoY (TTM)|CYTO (altamiratherapeutics.com) - Revenue Growth YoY (Last 12 Months)|LIPO - Annual Revenue Growth (Last Twelve Months)|Revenue Growth YoY (Last 12 Months) OPTN|Pieris Pharmaceuticals Inc (PIRS) - Annual Revenue Growth (Last Twelve Months)|Sales Growth YoY (TTM) PROC|PTPI: Trailing Twelve Months Sales Growth|Sales Growth YoY (Last Twelve Months) Qilian International QLI|Revenue Change YoY (Last 12 Months) SLRN (Acelyrin, Inc.)|TFFP - Sales Growth YoY (Last Twelve Months)